Not just numbers, but years of science: Putting the ACE inhibitor - ARB meta-analyses into context

International Journal of Cardiology

Volumn 166, Issue 2, 2013, Pages 286-288

  Ferrari, R ^a   Rosano, G M ^b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

ACE inhibitor; Angiotensin II receptor blocker; Mortality; Prognosis; Therapy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; CROMOGLYCATE DISODIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; COUGHING; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SECONDARY PREVENTION;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; HUMANS; META-ANALYSIS AS TOPIC;

EID: 84878016855     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.027     Document Type: Editorial

References (27)

1. S. Yusuf, K.K. Teo, and J. Pogue Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559
2. L.C. van Vark, M. Bertrand, and K.M. Akkerhuis Angiotensin-converting enzyme inhibitors reduce mortality in hypertension - a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone-system inhibitors involving 158,998 patients Eur Heart J 33 2012 2088 2097
3. G. Savarese, P. Costanzo, J.G. Cleland, E. Vasallo, G. Rosano, and P. Perrone-Fliardi Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on mortality and cardiovascular events in patients without heart failure. A meta-analysis of randomized clinical trials in 108,233 patients. Abstract 9641 Circulation 126 2012 A9641
4. F. Turnbull, B. Neal, and M. Pfeffer Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system J Hypertens 25 2007 951 958
5. M.H. Strauss, and A.S. Hall Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox Circulation 114 2006 838 854
6. S. Bangalore, S. Kumar, J. Wetterslev, and F.H. Messerli Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials BMJ 342 2011 d2234
7. Ferrari R, Boersma E. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review. Expert Rev Cardiovasc Ther submitted for publication.
8. C. Ma, J. Cao, and X.C. Lu Cardiovascular and cerebrovascular outcomes in elderly hypertensive patients treated with either ARB or ACEI J Geriatr Cardiol 9 2012 252 257
9. H. Haller, S. Ito, and J.L. Izzo Jr. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes N Engl J Med 364 2011 907 917
10. E. Imai, J.C. Chan, and S. Ito Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study Diabetologia 54 2011 2978 2986
11. S. Dimmeler, V. Rippmann, U. Weiland, J. Haendeler, and A.M. Zeiher Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide Circ Res 81 1997 970 976
12. J.L. Probstfield, and K.D. O'Brien Progression of cardiovascular damage: the role of renin-angiotensin system blockade Am J Cardiol 105 2010 10A 20A
13. C. Ceconi, K.M. Fox, and W.J. Remme ACE inhibition with perindopril and endothelial dysfunction. Results of a substudy of the EUROPA study: PERTINENT Cardiovasc Res 73 2007 237 246
14. R. Ferrari, and K. Fox Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story Drugs 69 2009 265 277
15. A. Cargnoni, L. Comini, and P. Bernocchi Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril Br J Pharmacol 133 2001 145 153
16. T. Unger Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications J Renin Angiotensin Aldosterone Syst 2 Suppl. 2 2001 S4 S7
17. E. Cangiano, C. Cavazza, and G. Campo ACE inhibition modulation of endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes Am J Cardiovasc Drugs 11 2011 189 198
18. C. Ceconi, G. Francolini, A. Olivares, L. Comini, T. Bachetti, and R. Ferrari Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE Eur J Pharmacol 577 2007 1 6
19. C. Ceconi, G. Francolini, D. Bastianon, G.L. Gitti, L. Comini, and R. Ferrari Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies Cardiovasc Drugs Ther 21 2007 423 429
20. K. Sekizawa, Y. Ujiie, S. Itabashi, H. Sasaki, and T. Takishima Lack of cough reflex in aspiration pneumonia Lancet 335 1990 1228 1229
21. A.H. Morice, R. Lowry, M.J. Brown, and T. Higenbottam Angiotensin-converting enzyme and the cough reflex Lancet 2 1987 1116 1118
22. K. Nakayama, K. Sekizawa, and H. Sasaki ACE inhibitor and swallowing reflex Chest 113 1998 1425
23. D. Caldeira, J. Alarcao, A. Vaz-Carneiro, and J. Costa Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis BMJ 345 2012 e4260
24. M.R. Hargreaves, and M.K. Benson Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough Lancet 345 1995 13 16
25. M. Hargreaves Sodium cromoglycate: a remedy for ACE inhibitor-induced cough Br J Clin Pract 47 1993 319 320
26. A. Keogh Sodium cromoglycate prophylaxis for angiotensin-converting enzyme inhibitor cough Lancet 341 1993 560
27. T.L. Allen, and M.L. Gora-Harper Cromolyn sodium for ACE inhibitor-induced cough Ann Pharmacother 31 1997 773 775